Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Patrik Brehm

Patrik Brehm

Preclinical Research Manager at Myelo Therapeutics

Connect with Patrik Brehm on LinkedIn

About the author: After studying biochemistry at the LMU in Munich and conducting his master’s thesis on the stem cell-like seam cells in C. elegans at the Imperial College London, Patrik joined Myelo Therapeutics in Dresden to direct the bulk of pre- and non-clinical research on Myelo001.

Posts by Patrik Brehm

Broadening the Field of Research While Staying Focused

Posted on June 7th, 2017 in Pharma R&D

Since joining The Hive, our team at Myelo Therapeutics has had the opportunity to train on and utilize a number of Elsevier’s information solutions, and they have already made a significant impact on our work, whether using Scopus to find collaborators or analyzing chemical structures with Reaxys. (more…)

Logistics of Time and Tools

Posted on March 24th, 2017 in Pharma R&D

One might imagine that most start-up companies have their employees huddled together in a single small location, but communication technology has made it far more feasible for innovators to collaborate across distances. (more…)

Working to Uncover the Mode of Action

Posted on March 2nd, 2017 in Pharma R&D

The New Year has brought some new talent into the Myelo Therapeutics team. In January we welcomed Susann, our new postdoctoral researcher. We’re excited to have someone with her experience, which includes studying molecular biology in Dresden and Heidelberg, (more…)

An Update from Myelo: Expanding Our Team and Evaluating Data

Posted on December 14th, 2016 in Pharma R&D

The focus of our current non-clinical research at Myelo Therapeutics is to fully elucidate the mode of action for prevention of myelosuppression as well as Myelo001’s antiviral capabilities. But to achieve this goal, it’s important to have highly skilled and motivated personnel within your team. (more…)